Helix BioPharma Corp. (TSX: HBP)
Health Care · Biotechnology · CA
CA$0.98
+6.52% today · -54.0% 1Y
Helix BioPharma Corp. (TSX: HBP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $52.92M and employs 7 people.
Over the last twelve months the share price has lost 54.0%, trading between 0.85 and 2.75.
Tweenvest scores Helix BioPharma Corp. across four factors: quality 43/100, value 58/100. Its strongest factor is value.
HBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $52.92M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- -0.14
- 52-week high
- CA$2.75
- 52-week low
- CA$0.85
- Avg volume (3M)
- —
- Shares outstanding
- 76.38M
- Employees
- 7
- Next earnings
- —
About Helix BioPharma Corp.
Based in Richmond Hill, Canada, Helix BioPharma Corp. is a Canadian immune-oncology company focused on therapeutic development. The firm is progressing L-DOS47 for treating non-small cell lung cancer and is also working on V-DOS47, which targets the vascular epithelial growth factor receptor 2. Helix BioPharma has formed strategic alliances, including one with Moffitt Cancer Center to analyze L-DOS47's pharmacodynamics and assess the benefits of integrating it with immune checkpoint inhibitors. Another partnership, with ProMab Biotechnologies, Inc., is dedicated to creating innovative antibody and chimeric antigen receptor T-cell therapies to combat multiple myeloma. Furthermore, the company maintains licensing agreements with Xisle Pharma Ventures Trust and the National Research Council Canada.
- ISIN
- CA4229102088
- Founded
- 2008
- Listed since
- Aug 13, 1996
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Boundless Bio, Inc.NasdaqGS: BOLD | $55.27M | $2.43 | +5.19% |
| Synthaverse S.A.WSE: SVE | $55.01M | zł2.81 | -0.88% |
| Gain Therapeutics, Inc.NasdaqGM: GANX | $54.99M | $1.26 | -23.17% |
| Adocia SAENXTPA: ADOC | $53.73M | €2.40 | -1.32% |
| OSE Immunotherapeutics SAENXTPA: OSE | $52.78M | €2.00 | -1.86% |
| Sirnaomics Ltd.SEHK: 2257 | $52.66M | HK$3.80 | +1.34% |
| UBI Pharma Inc.UNQ: 6562 | $52.10M | NT$— | — |
| CG Invites Co., Ltd.KOSDAQ: A083790 | $52.02M | ₩902.00 | -3.01% |
Figures last refreshed Oct 18, 2026.